Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) fell 10.6% in the pre-market session after the company reported underwhelming fourth quarter results, with EPS missing Wall Street estimates and full-year EPS guidance falling significantly short. However, full-year revenue guidance slightly exceeded analysts' expectations, and revenue outperformed estimates. Overall, the results were mixed.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Molina Healthcare? Access our full analysis report here, it’s free.
Molina Healthcare’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. Moves this big are rare for Molina Healthcare and indicate this news significantly impacted the market’s perception of the business.
Molina Healthcare is up 0.7% since the beginning of the year, but at $289.18 per share, it is still trading 31.1% below its 52-week high of $419.53 from March 2024. Investors who bought $1,000 worth of Molina Healthcare’s shares 5 years ago would now be looking at an investment worth $2,259.
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。